Svein Jacob Kaspersen

Structure–activity study leading to identification of a highly active thienopyrimidine based EGFR inhibitor

Steffen Bugge, Svein Jacob Kaspersen, Synne Larsen et al. · European Journal of Medicinal Chemistry · 2014 · 64 citations

Molecular Pharmacology, Biochemistry, Active Thienopyrimidine +10

Synthesis and in vitro EGFR (ErbB1) tyrosine kinase inhibitory activity of 4-N-substituted 6-aryl-7H-pyrrolo[2,3-d]pyrimidine-4-amines

Svein Jacob Kaspersen, Christopher Sørum, Veronica Willassen et al. · European Journal of Medicinal Chemistry · 2011 · 37 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Biochemistry +7

Chiral 6-aryl-furo[2,3-d]pyrimidin-4-amines as EGFR inhibitors

Jin Han, Svein Jacob Kaspersen, Sondre Nervik et al. · European Journal of Medicinal Chemistry · 2016 · 34 citations · Full text

Medicinal Chemistry, Medicine, Egfr Inhibitors +5

Activity of 6-aryl-pyrrolo[2,3-d]pyrimidine-4-amines to Tetrahymena

Svein Jacob Kaspersen, Eirik Sundby, Colin Charnock et al. · Bioorganic Chemistry · 2012 · 28 citations · Full text

Bioorganic Chemistry, Natural Sciences, Organic Chemistry +3

Identification of new 4-N-substituted 6-aryl-7H-pyrrolo[2,3-d]pyrimidine-4-amines as highly potent EGFR-TK inhibitors with Src-family activity

Svein Jacob Kaspersen, Jin Han, Kristin G. Nørsett et al. · European Journal of Pharmaceutical Sciences · 2014 · 28 citations

Medicinal Chemistry, Biochemistry, Src-family Activity +11